Resources

Contact lenses, either therapeutic or corrective, should be removed before applying OXERVATE. Contact lenses may be reinserted 15 minutes after OXERVATE administration.

Eye Discomfort, such as eye pain, that can be mild to moderate can occur with OXERVATE. Patients should contact their health care provider if a more serious eye reaction occurs.

ADVERSE REACTIONS

The most common adverse reaction with OXERVATE (~16%) was eye pain. Other adverse reactions with OXERVATE (1% to 10%) included corneal deposits, foreign body sensation, ocular hyperemia, ocular inflammation, photophobia, tearing, and headache.

Please read the full Prescribing Information for OXERVATE.

Resources

For eye care professionals

OXERVATE® (cenegermin-bkbj) Prescribing Information

HCP DC2C Overview

DC2C Enrollment Form

iAssist One Pager

OXERVATE (cenegermin-bkbj) Administration

For office staff

DC2C Enrollment Form

HCP DC2C Overview

iAssist One Pager

OXERVATE (cenegermin-bkbj) Administration

For patients

OXERVATE (cenegermin-bkbj) Patient Quickstart Guide

Patient DC2C Roadmap

OXERVATE (cenegermin-bkbj) Administration

Sign up for additional resources and to stay up to date about OXERVATE®

Thank you!

Important Safety Information

WARNINGS AND PRECAUTIONS

ADVERSE REACTIONS

OXERVATE^® (cenegermin-bkbj) Prescribing Information

Sign up for additional resources and to stay up to date about OXERVATE^®